Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVRx, Inc. stock logo
CVRX
CVRx
$7.08
-10.0%
$7.64
$4.30
$18.55
$185.14M1.26307,979 shs160,262 shs
Electromed, Inc. stock logo
ELMD
Electromed
$24.68
+3.4%
$20.53
$17.73
$35.56
$205.39M0.5485,043 shs42,703 shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.03
+0.4%
$8.02
$4.61
$11.04
$204.87M1.82180,492 shs238,185 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.15
-0.9%
$4.06
$3.03
$9.33
$51.79M1.41180,330 shs79,907 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVRx, Inc. stock logo
CVRX
CVRx
0.00%+0.64%+11.95%+33.84%+0.25%
Electromed, Inc. stock logo
ELMD
Electromed
0.00%-2.41%+26.15%+18.69%+30.99%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-1.67%+3.74%+56.58%+53.46%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-1.55%-5.07%-34.02%-47.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVRx, Inc. stock logo
CVRX
CVRx
$7.08
-10.0%
$7.64
$4.30
$18.55
$185.14M1.26307,979 shs160,262 shs
Electromed, Inc. stock logo
ELMD
Electromed
$24.68
+3.4%
$20.53
$17.73
$35.56
$205.39M0.5485,043 shs42,703 shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.03
+0.4%
$8.02
$4.61
$11.04
$204.87M1.82180,492 shs238,185 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.15
-0.9%
$4.06
$3.03
$9.33
$51.79M1.41180,330 shs79,907 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVRx, Inc. stock logo
CVRX
CVRx
0.00%+0.64%+11.95%+33.84%+0.25%
Electromed, Inc. stock logo
ELMD
Electromed
0.00%-2.41%+26.15%+18.69%+30.99%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-1.67%+3.74%+56.58%+53.46%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-1.55%-5.07%-34.02%-47.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVRx, Inc. stock logo
CVRX
CVRx
2.86
Moderate Buy$14.0097.74% Upside
Electromed, Inc. stock logo
ELMD
Electromed
3.33
Buy$36.2546.87% Upside
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
4.00
Strong Buy$12.5024.69% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00153.97% Upside

Current Analyst Ratings Breakdown

Latest SRTS, INFU, CVRX, and ELMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$36.00
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$29.00 ➝ $35.00
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$36.00
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$13.00 ➝ $6.00
8/5/2025
CVRx, Inc. stock logo
CVRX
CVRx
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$11.00
7/22/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$29.00
7/22/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$12.00
7/21/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/21/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/7/2025
CVRx, Inc. stock logo
CVRX
CVRx
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVRx, Inc. stock logo
CVRX
CVRx
$51.29M3.61N/AN/A$2.93 per share2.42
Electromed, Inc. stock logo
ELMD
Electromed
$64M3.22$0.60 per share41.36$5.10 per share4.84
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$139.89M1.46$0.78 per share12.79$2.47 per share4.06
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.24$0.43 per share7.36$3.41 per share0.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVRx, Inc. stock logo
CVRX
CVRx
-$59.97M-$2.10N/AN/AN/A-95.61%-79.31%-40.96%11/4/2025 (Estimated)
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$0.8432.80N/A11.34%15.71%13.37%N/A
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$870K$0.23167.1932.34N/A1.12%2.78%1.41%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A13.70N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)

Latest SRTS, INFU, CVRX, and ELMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
8/4/2025Q2 2025
CVRx, Inc. stock logo
CVRX
CVRx
-$0.52-$0.57-$0.05-$0.57$13.22 million$13.59 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVRx, Inc. stock logo
CVRX
CVRx
0.85
11.99
10.78
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.50
1.98
1.59
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79

Institutional Ownership

CompanyInstitutional Ownership
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
71.13%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
CVRx, Inc. stock logo
CVRX
CVRx
18.90%
Electromed, Inc. stock logo
ELMD
Electromed
14.00%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
11.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVRx, Inc. stock logo
CVRX
CVRx
16026.15 million21.21 millionOptionable
Electromed, Inc. stock logo
ELMD
Electromed
1608.35 million7.36 millionOptionable
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
41020.43 million19.10 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVRx stock logo

CVRx NASDAQ:CVRX

$7.08 -0.79 (-10.04%)
As of 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Electromed stock logo

Electromed NYSE:ELMD

$24.68 +0.80 (+3.36%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

InfuSystem stock logo

InfuSystem NYSE:INFU

$10.02 +0.04 (+0.35%)
As of 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.15 -0.03 (-0.94%)
As of 02:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.